Latest news
Friday Five – The short-lived story of BristolZeneca...and more from a busy week in biopharma - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 14:56:57 GMTBourla pushes back on claims of Pfizer's shrinking M&A firepower - FirstWord PharmaFirstWord Pharma · Tue, 04 Aug 2026 18:06:57 GMTRolls-Royce's Dividend Return Caps a Stretch of Beating the Street - AD HOC NEWSAD HOC NEWS · Tue, 04 Aug 2026 16:25:00 GMTSolvar's 12% Fully Franked Yield and Special-Dividend Firepower: Is This Small-Cap Lender Australia's Hidden Income Machine? - KalkineKalkine · Mon, 03 Aug 2026 00:42:00 GMT